Stock Comparison

RDY vs TAK

Dr. Reddy’s Laboratories Ltd ADR and Takeda Pharmaceutical Co Ltd ADR side by side — valuation, profitability, growth and risk.

RDY

Dr. Reddy’s Laboratories Ltd ADR

Healthcare

TAK

Takeda Pharmaceutical Co Ltd ADR

Healthcare

Valuation

Market Cap

$10.42B

$55.20B

P/E (TTM)

29.8

—

Forward P/E

27.2

10.6

Price/Sales

0.0

Price/Book

2.6

1.2

EV/EBITDA

14.5

22.6

Dividend Yield

0.66%

1.85%

Profitability

Net Margin

12.72%

4.25%

Operating Margin

14.74%

10.89%

Return on Equity

8.84%

-2.26%

Return on Assets

4.01%

2.69%

Growth (YoY)

Revenue Growth

-5.60%

10.20%

Earnings Growth

-68.70%

-9.80%

Price & Risk

Beta

0.2

0.1

52-Week High

$15.40

$18.80

52-Week Low

$11.40

$13.23

Analyst Target

$13.54

$21.59

Compare RDY and TAK your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.